|
It was reported that the right ventricular (rv) lead exhibited t-wave oversensing (twos) post ventricular pace.Re-programming was done on the lead, but there was further twos.Further re-programming was done, and further twos was noted.The lead remains in use.No patient complications have been reported as a result of this event.
|
|
Product event summary: the lead was not returned for analysis, however, performance data collected from the device was received and analyzed.Analysis of the device memory indicated t-wave oversensing.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|